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Abstract
MEMRI offers the exciting possibility of tracing neuronal circuits in living animals by MRI. Here
we use the power of mouse genetics and the simplicity of the visual system to test rigorously the
parameters affecting Mn2+ uptake, transport and trans-synaptic tracing. By measuring electrical
response to light before and after injection of Mn2+ into the eye, we determine the dose of Mn2+ with
the least toxicity that can still be imaged by MR at 11.7T. Using mice with genetic retinal blindness,
we discover that electrical activity is not necessary for uptake and transport of Mn2+ in the optic
nerve but is required for trans-synaptic transmission of this tracer to distal neurons in this pathway.
Finally, using a kinesin light chain 1 knock-out mouse, we find that conventional kinesin is a
participant but not essential to neuronal transport of Mn2+ in the optic tract. This work provides a
molecular and physiological framework for interpreting data acquired by MEMRI of circuitry in the
brain.
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Introduction
Manganese-enhanced MRI (MEMRI) allows tracing of neuronal tracts in living animals, and
thus offers the potential to image changes in circuitry by sequential imaging over time during
evolution of disease or following exposures to experiences or drugs(Lin and Koretsky, 1997;
Pautler et al., 2003). A dependence of Mn2+ uptake on neuronal electrical activity raises the
possibility of tracing the anatomy of functional circuits. These are very exciting experimental
possibilities that require rigorous testing for reliable interpretation.
Track tracing of neuronal circuits relies on a normal neuronal activity: intracellular transport.
Typically tracers injected into the brain enter neurons locally and are picked up by the
intracellular transport machinery and then carried along neuronal processes to reach distant
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synapses or cell bodies(Fritzsch, 1993; Grafstein and Forman, 1980; Lanciego et al., 2000).
Transport from the synapse back to the cell body is termed “retrograde,” and from the cell body
towards the synapse “anterograde”. Fast axonal transport occurs in both directions and is
powered by molecular motors specific for each direction: anterograde is mediated by kinesins
and retrograde by dynein and a subset of retrograde kinesins (Chevalier-Larsen and Holzbaur,
2006; Muresan, 2000; Shea and Flanagan, 2001).
The optic tract serves as an excellent test bed for monitoring transport because of its large size
(∼1mm in diameter) and because the majority of the axons within it are oriented in the same
direction-- arising from retinal ganglion cells in the eye and projecting towards the lateral
geniculate nuclei and the superior colliculus in the midbrain. Thus movement of tracers towards
the brain in the optic nerve can be assumed to occur in the anterograde direction, i.e. out from
the cell body, and movement towards the eye in the retrograde direction. Injection of radioactive
tracers into the posterior chamber of the eye demonstrates rapid anterograde transit (2mm/hr)
from the eye along the optic nerve towards the brain(Grafstein and Forman, 1980). Replicating
these experiments by intravitreous injection of Mn2+ followed by MR imaging demonstrated
that Mn2+ is also transported, possibly at the same rate (Pautler et al., 1998), along the optic
nerve and crosses synapses to reach the visual cortex(Pautler, 1999; Pautler et al., 1998; Thuen
et al., 2005; Watanabe et al., 2001; Watanabe et al., 2004).
Here, we use the power of mouse genetics to determine whether neuronal activity is required
for Mn2+ transport and/or trans-synaptic tracing. We first test the effect of injecting Mn2+ into
the eye on neuronal activity in the visual system. We then determine the maximum amount of
Mn2+ that can be used to trace pathways without long-lasting damage to vision, as assessed by
both physiological and morphological criteria. Next, we test whether Mn2+ transport is
dependent on electrical activity by tracing this pathway in a blind mouse, the inbred CBA
strain, lacking active photoreceptors(Caley et al., 1972). This mouse carries the rd mutation
and has no rod light detector cells in the retina(Bowes et al., 1990). Retinal ganglion cells are
intact and give rise to a robust optic nerve, but due to the absence of photoreceptor cells there
is no electrical activity in the visual system in response to light. Capturing T1 weighted
microMRI images at 6-minute intervals in an 11.7T MR system allowed detailed observation
of transport dynamics in these various genotypes at short time intervals. Thus, minor
differences in transport properties could be detected. Finally, using mice lacking the kinesin
light chain 1 gene, KLC1−/− (Rahman et al., 1999), we test whether anterograde transport of
Mn2+ is dependent on the hetero-tetrameric conventional kinesin motor coupled to this light
chain. In each case, mutant mice were compared to parental strains or genetically normal
littermates subjected to the same experimental protocol. Our data show that electrical activity
is not required for uptake and transport of Mn2+ but is required for trans-synaptic transmission,
and that conventional kinesin is not the only motor involved in Mn2+ transport.
Materials and Methods
Mouse genotypes
CBA/J mice and littermate controls at 6-12 weeks of age were obtained from Jackson Labs
(Bar Harbor, ME). Sighted C57LB/6 and blind CBA (rd1−/− with retinal blindness) were
analyzed for the rd1 mutation, which causes retinal blindness due to loss of photoreceptor cells.
CBA/J strain carries a proviral insert in the first exon of the Pdeb gene, encoding the B-subunit
of cGMP phosphodiesterase. Genotypes were confirmed using PCR across the transposable
element insert using three primers (Table 1) as described (Gimenez and Montoliu, 2001) except
for a slight correction in the RD6 primer sequence to match the accession, L02110, nucleotides
2539-2512. C57/b6 strain were used for comparison with CBA. Ten CBA mice were imaged,
5 young (6-8 weeks old) and 5 older (7-8 months old).
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Kinesin light chain 1 deficient mice were previously generated by homologous recombination
in a mixed 129/C57BL/6J background (Rahman 1999). Mutant mice were backcrossed into a
pure C57BL/6J background for more than 12 generations. G12 male and female's heterozygote
mice for KLC1 deletion were crossed against each other to obtain wild type and homozygotes
mutant littermates that were used in the experiments. Mice genotyping was performed by PCR
amplification of wild type and recombinant KLC1 alleles using DNA extracted from tails
(Rahman 1999). Twenty-two KLC mice were examined in this study, 8 KLC−/− and 12 KLC
+/+ and 2 KLC+/−. Results were highly consistent, and examples were selected to represent
the average pattern to show here.
Visual Evoked potentials
Visual evoked potentials were measured before, and at 3 and 24 hours after injection of
Mn++ into the eye using a strobe light and Labview software as described(Martin et al.,
2006). Mice were anesthetized with vaporized isofluorane (1% in oxygen) and placed in a dark
box kept at 37°C with a water heating pad. Three electrodes were placed, one just dorsal to the
interorbital line (for measurement), the second at the nuchal crest (for reference), and the third
on a rear leg (as ground). Labview software was used to collect 250 data points at a sample
rate of 1 kHz recording electrical activity in response to each flash of light from a strobe light
with a flash frequency of 2 Hz. Flash and measurement collection were synchronized by an
external source. Data from 5 repeats of 100 flash/response measurements were averaged for
each mouse at each session. VEPs were collected before Mn2+ injection, at 4 hr and 24 hr after
Mn2+ injection. Input from both eyes open, one or the other eye closed, and both eyes closed
were measured.
Morphological examination—Mice were anesthetized 4 months after the last MRI and
sacrificed by ex-sanguination via intracardiac perfusion with a 30ml washout with warm
heparinized phosphate buffered saline (PBS) followed by 50 ml of 2% paraformaldehyde
(PFA) and 2.5% gluteraldehyde in 0.06 M phosphate buffer pH 7.2 at a rate of 5 ml/min. The
carcass was decapitated and the head rocked in 4% PFA in PBS overnight at 4°C. All
procedures were according to protocols approved by the University Committee on Animal
Resources. Retina and optic tracks were dissected, diameters measured in a steroscope, and
then 1mm blocks stained in aqueous 4% OsO4 at 4°C, 1% tannic acid in 0.05M Na-Cacodylate
pH 7.0, followed by 0.5% Uranyl acetate in veronal acetate at 37°C, dehydrated and embedded
in Epon 812. Semi-thin sections stained with toluidine blue were examined histologically for
numbers and size of axons with a Zeiss axioscope and images captured with the Axiocam.
Axons were counted in 4,500 μm2 selected at random on printouts of histologic images captured
at 63x magnification. Approximately 1000 axons were counted per optic tract and the average
number calculated with Kaleidograph.
Magnetic resonance imaging—MnCl2 (200 mM) was injected into the vitreous of the
right eye. A fine steel needle (30 gauge, 0.3mm) was used to bore a hole in the sclera through
which the Mn2+ solution was injected via a pulled glass micropipette (∼10 μm tip size). The
volume of injectate was monitored by calibrating the micropipette and controlling injection
with a pressurized controlled picospritzer (Parker Hannifin, Cleveland, OH). MR images were
acquired with an 11.7T 89 mm vertical bore Bruker BioSpin Advance DRX500 scanner(Bruker
BioSpin Inc, Billerica, MA) using a 20mm RF birdcage coil. Slab images of the optic tract
(0.45cm thick slab with 32 axial slices) were acquired at 6 minute intervals for 2 hours
beginning 30 minutes post injection with a 3D RARE sequence (TR/TE 300/5 ms, 4 echoes,
1 averages, FOV 1.52×0.45 cm, and 1282×32 matrix size for a voxel size of 140×110× 140
μm). Whole brain images were acquired at 24 h after MnCl2 injection with a T1 weighted 3D
UFLARE sequence (TR/TE 300/5 ms, 4 echoes, 2 averages, FOV 2.2×1.52 cm, and
256×1282 matrix size). Fro 24 hr images, standard tubes of water and of a known concentration
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of gadolinium in solution and were taped to the mouse head to provide a standard for
normalization of intensity values. MR images were visualized in ImageJ software and intensity
normalized by setting all images to the same gray scale of the standards. In some instances,
two axial slices were averaged to encompass the optic nerve as it is not straight and sometime
passed out of a single slice.
ROI analysis—For analysis of dynamic imaging series, MR images from the 6 min captures
were transported to ImageJ directly from the Bruker raw data. For each stack, the three slices
passing through the optic track were average using Image>Stacks>Z-project. An ROI of 9
voxels was place over the optic track 1 cm from the back of the eye in the 3-slice averaged
image captured at the later time point in the dynamic series when the optic track was most
easily visible. The intensity was then measured in this ROI in each image in the series,
beginning at the last and moving through the stack to the first without moving the ROI. Intensity
in the cheek muscle was measured in parallel in each image. Average voxel intensity for each
ROI in the optic track was divided by average intensity in the cheek muscle. Standard deviations
in each measurement were averaged and the sum used as error bars. Unpaired student t-test
was used to determine statistical significance between intensity in the wild type KLC+/+ versus
in the KLC−/− in the dynamic series. For analysis of transport in the LGN and superior
colliculus, similar ImageJ approach was used. The coronal slice with the most intense signal
in the expected midbrain region was selected for each structure from the whole brain 24 hr 3D
T1-weighted image in coronal slices. Again, average voxel intensity was acquired through an
ROI of 9 voxels with ImageJ on single slices. A ROI of 26 voxels was selected in the same
slice in the cheek muscle to normalize intensity measurements across scans. Intensity in the
midbrain regions were divided by intensity in the standard tube. Average standard deviations
were summed.
Results and Discussion
The minimal dose of MnCl2 that produced reversible toxicity and MR signal
Previous tracing with MEMRI in the visual system has typically used volumes of 1-3 μl and
MnCl2 concentrations up to 1.0 M for injection into either the anterior chamber of the mouse
eye (Lindsey et al., 2007) or the posterior chamber of the rat eye(Thuen et al., 2005). We noted
that the eyes of animals so injected turned gray, and physical exam suggested that they could
no longer see. We thus set out to measure visual light response as a means to determine
functional effects of the injection of MnCl2 on the retinal neurons and the visual system.
Light is detected in the retina by photoreceptors, which transmit signals to retinal ganglion
cells that then send electrical potentials along the optic tract to the visual cortex. The electrical
potential evoked by light can be measured over the visual cortex of the brain with externally
placed electrodes and provides a measure of whether the visual pathway is intact. Thus, visual
evoked potentials (VEP) measured before and after MnCl2 injection into the eye can reveal
the effect of Mn2+ on electrical activity in response to light in the visual pathway (Fig. 1).
Before injection, the VEP of C57 (wild type) mice was robust (Fig. 1A, top). Four hours after
injection of 0.5 μl of 200 mM MnCl2 into the right eye, no response to light was detected even
with both eyes open. Even at 24 hr after injection, only a small late potential change was
detected. Thus injection in one eye affects visual responses in the entire visual track, possibly
due to cation-induced hyperpolarization in the injected eye that propagates to the visual cortex
rendering it unresponsive to input from either eye.
This toxicity could be either due to MnCl2 or to an increase in intraocular pressure caused by
the volume of injectate. We tested a volume effect by injecting a similar amount of saline. A
similar volume of saline (0.5 μl) also depressed VEPs at 4 hr after injection, but complete
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recovery was evident at 24 hr (Fig. 1B). Hence, at this volume and concentration of MnCl2
there was a volumetric effect.
Smaller volumes of MnCl2, 0.25 μl, still depressed the light response at 4 hr but some return
of function was apparent at 24 hr (Fig. 1C). Even a smaller volume, 0.125 μl and lower
concentration of MnCl2 (50 mM) still depressed the VEP response at 4 hr but allowed full
recovery at 24 hr (Fig. 1D). Injections of 0.25 μl of saline did not cause VEP depression (Fig.
2A). Thus, 0.25 μl has no volumetric effect, and the VEP depression with this volume of
MnCl2 is due to the ionic composition and not the volume. Unfortunately, we could not detect
optic track enhancement with a lower dose of Mn2+, 0.125 μl at 50 mM. (data not shown).
Thus, even doses of Mn2+ lower than can be detected by our 11.7T MR system depress VEPs
at 4 hr after injection into the vitreous. It may be possible to detect MR signal from a lower
Mn2+ dose with a 7T field strength. Injection into the anterior chamber could also mitigate
toxicity.
Since visual response recovered at 24 hr after 0.25 μl injection of 200 mM MnCl2, and since
this dose produced a contrast signal detectible by MRI in the optic pathway, we opted for a
0.25 μl injection of 200 mM MnCl2 for all subsequent experiments described here.
CBA mice had no response to light in the visual system
Preinjection VEPs detected no response to light in the visual system in 4-6 week old CBA mice
positive for the rd mutation by PCR (Fig. 2B). Similar lack of response was measured in older
CBA (7-14 months old). Thus, these mice are functionally blind with no detectible electrical
signals in the visual pathway by VEP.
Time-lapse MR imaging of Mn2+ transport in the optic nerve revealed no obvious difference
between blind and sighted mice
To image Mn2+ during transport into the optic nerve immediately after injection into the eye,
we developed a pulse sequence to capture a 32-slice slab image every 6 minutes, beginning 30
min and continuing for 2 hr to conclude at 2.5 hr after injection (Fig. 3). In both C57 sighted
and CBA blind mice, either young (4-6 weeks) or old (10 month), Mn2+-induced signal
enhancement appeared along the optic nerve over the first 2.5 hr with bright delineation of the
optic tract at 24 hr.
At 30 minutes after injection MR images displayed hyper-intense signal in the vitreous of the
eye that gradually decreased with time as intensity increased along the optic nerve (Fig. 3). At
30 min, signal was present in the optic nerve emerging from the eye. Over the next 2 hr, signal
along the optic tract gradually increased, with no defined wave front. The rate of increase in
Mn2+-induced signal enhancement along the optic nerve is dependent on uptake into the
ganglion cells in the retina, accumulation inside the cell, and transport along their axons. Signal
enhancement was detectible at the chiasm, ∼1.2 cm from the eye, at 2.5 hr suggesting a minimal
transport rate of 5 mm/hr consistent with fast anterograde transport of organelles in the optic
system (Brady et al., 1982;Lavail et al., 2005;Martin et al., 1999;Satpute-Krishnan et al.,
2003;Shah and Cleveland, 2002).
The rate of appearance of Mn2+ signal along the optic nerve appeared similar in sighted and
blind mice at all ages studied. This similarity demonstrates that uptake and transport are
independent of electrical activity in the eye and along the optic nerve. Thus while Mn2+can
enter through voltage-dependent calcium channels(Merritt et al., 1989), it may also enter
neurons through other ion channels, such as divalent metal transporters(Thompson et al.,
2007). Once inside the cell, Mn2+ must complex with other molecules or enter subcellular
compartment(s) for fast transport. Different compartments are known to travel at different rates
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in the axon(Brady et al., 1982; Grafstein and Forman, 1980; Satpute-Krishnan et al., 2006;
Thompson et al., 2007; Vale et al., 1985). For example mitochondria travel slowly (0.05-0.3
μm/sec)(Satpute-Krishnan et al., 2003) while transport vesicles in neurons may travel as fast
as 5 μm/sec (Vale et al., 1985). Mn2+ may enter more than one of these compartments, and
thus travel at various rates in the same axon.
Fewer axons are found in the optic nerve of injected eyes
Optic nerves from CBA and C57 mice fixed by perfusion several months after eye injections
were examined by histology (Fig. 4) and electron microscopy (Fig. 5). By both whole mounts
and in histology, the diameter of the optic nerve on the Mn2+ injected side was 6% less than
the un-injected side (Fig. 4A, uninjected C57, Fig. 4C, injected C57, and Fig. 4D, injected
CBA). This was true in either the blind CBA or the sighted C57 mouse. Histologic examination
at higher magnification (Fig. 4B, E and F) suggested that in addition to decreased optic nerve
diameter, there was a loss of axons and a replacement by glial or other repair tissue. Counts of
axon numbers at higher magnification of histologic sections revealed 391 +/− 17 axons per 4.5
×103 μm2 in the optic track of the un-injected (left) side of a C57 sighted mouse (Fig. 4B), and
similar numbers in un-injected CBA mice. After injection, both CBA and C57 mice displayed
fewer axons per cross sectional area of the optic nerve, with only 291 +/−4.6 axons per 4.5
×103 μm2 in the optic nerve of C57 mice and 281 +/− 4.7 axons in CBA. Thus injection into
the eye results in ∼25% decrease in the number of axons per unit area in either blind or sighted
mice. No inflammation or infection was observed in any of the histologic sections. Saline
injected axons were not examined, as similar volumes produced no VEP defect and thus no
axonopathy is expected.
By electron microscopy (Fig. 5) axons in the optic nerve of injected eyes from either C57-
sighted or CBA-blind mice were comparable, with similar myelination and equivalent presence
of neurofilaments, microtubules and mitochondria. CBA axons appeared normal in all
morphological respects despite the lack of electrical stimulation from photoreceptors. Thus
ultrastructural analysis of surviving axons revealed no evidence of on-going toxic effects at
this time point after injection.
Transport is slowed but not abolished in KLC1−/− mice
Neuronally enriched KLC1 is one of three light chains that alternatively bind to conventional
kinesin heavy chain, Kif5, to form the heterotetrameric kinesin motor(Johnson et al., 1990;
Lamerdin et al., 1996; Rahman et al., 1998; Rahman et al., 1999).
To test whether this form of kinesin was involved in Mn2+ transport, we used KLC1 knockout
mice that lack this type of light chain(Rahman et al., 1999; Vale et al., 1985). These mice have
alterations in kinesin behavior. At 24 hr after injection into the right eye, enhancement of the
optic tract in KLC1 knockouts was similar to littermates. However at earlier time points
Mn2+ enhancement developed more slowly (Fig. 6). At 2.5 hr after injection, the optic track
remained difficult to identify in KLC1 −/− mice, even though in all other mice assessed
enhancement was obvious by this time point. Because accumulation of signal is gradual, this
difference might not have been detected had we only captured 24 hr images.
Since Mn2+ enters cells and associates either with protein complexes or membranes, it may
associate with a subset of cargo complexes that depend on KLC1 for their transport(Bowman
et al., 2000; Kamal et al., 2000; Verhey et al., 2001). The lack of KLC1 in mutants would thus
produce a decrease in the number and/or speed of Mn2+-containing vesicles being transported
and thus a delay in the early wave of Mn2+ transport towards the chiasm, as observed here in
the time-lapse sequence. By 24 hr this slower accumulation was sufficient to produce signal
along the optic tract similar to C57/b6 and to littermates with KLC1+/+ genotype. Hence
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similarity at later time points to wildtype may be explained by the transport of Mn2+ in KLC1
−/− being mediated by motors other than conventional kinesin with the KLC1 light chain.
ROI analysis of the intensity changes in the optic track during the first 2.5 hr after injection
demonstrate that in KLC+/+ intensity increased at 1 cm from the eye by 150% while in KLC
−/− no increase is detected (Fig. 6C). Unpaired students t-test demonstrated that this difference
in intensity has a probability of 0.0001 of occurring by chance.
Repair is depressed in KLC1 knockout mice
VEP analysis of KLC1 knockouts revealed a defect in restoration of the normal light response
at 24 hr after Mn2+ injection (Fig. 7). In normal littermates, VEPs at 24 hr were analogous to
pre-injection depolarizations after right eye injection, with only a slight delay in response and
minor alterations in voltage restitution after depolarization (Fig. 7A). In KLC knockouts, at 24
hr after Mn2+ injection into the right eye, voltage change in response to light was both delayed
and depressed (Fig. 7B). Thus, these KLC1 −/− animals do not repair the visual system as
completely as the other genotypes surveyed here, which could also be a consequence of
decreased transport.
Trans-synaptic tracing by Mn2+ requires neuronal activity
Previous studies have demonstrated that Mn2+ signal crosses synapses and thus traces circuits
beyond those of single neuronal projections(Murayama et al., 2006; Pautler et al., 2003; Saleem
et al., 2002). To determine whether this trans-synaptic transmission was dependent on neuronal
activity, studies have relied on experiential stimulation of the particular pathway involved.
However, to apply Mn2+ tract tracing to unknown pathways, it will be important to know
definitively whether trans-synaptic transmission requires neuronal activity. The blind mice
used in this study provide a more rigorous test for this analysis.
Mn2+ injection into the eye results in tracing of the visual system across at least two synapses:
first, retinal ganglion cell projections onto the midbrain, and second, midbrain neurons onto
the visual cortex(Lindsey et al., 2007; Murayama et al., 2006; Pautler et al., 1998; Thuen et
al., 2005; Watanabe et al., 2001). The amount of transfer across synapses appears to correlate
with axonal caliber (Murayama et al., 2006).
Three dimensional whole brain images of mouse brains 24 hr after Mn2+ injection into the eye
resulted in Mn2+-induced enhancement in the midbrain of KLC1+/+ wildtype, and KLC−/−
mice, despite the initial slower transport in the knockouts (Fig. 8). However, in blind mice
lacking neuronal activity in the visual system, little Mn2+ signal was detected in either the
lateral geniculate nucleus or the superior colliculus in the midbrain. This is despite robust signal
along the optic track and an equivalent number and caliber of axons as determined by our
histological examination reported earlier in this paper (Fig. 4-5).
ROI analysis of the intensity in the eye, optic track and midbrain in the three types of mice
examined here (wildtype, KLC−/− and CBA) at 24 hr after eye injection (Fig. 8B) demonstrated
(1) similar intensity in all three mice in the eye, (2) slight (20%) decrease intensity in the optic
tract in KLC−/− and CBA compared to wildtype, (3) significantly less intensity (80-90% less)
in midbrain trans-synaptic sites in blind (CBA) compared to wildtype and KLC−/− mice.
Thus, while Mn2+ uptake and transport within the neuron occur independent of electrical
activity, Mn2+ is not transmitted efficiently across synapses in the absence of electrical activity
in this system.
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Conclusion
Here we show that Mn2+ injection into the eye disrupts the electrical response to light in the
visual system. At high volumes (>0.25 μl) of injectate there is a volumetric effect. At low
volumes (in mouse, <0.25 μl of 200 mM) a transient effect on VEP which reverses after 24 hr
was observed with Mn2+ but not with saline. Even at these low amounts, a permanent loss of
10-20% of the axons in the optic nerve was found. Hence Mn2+ exposure may have long-term
effects on neurons. Uptake and transport of Mn2+ in the optic nerve occurred in blind mice
with no detectible electrical activity in the visual system. Thus Mn2+ does not require electrical
activity to enter neurons and trace their individual processes. However, Mn2+ did not appear
in the midbrain in blind mice, demonstrating that Mn2+ required neuronal activity to cross these
synapses. Mice defective in one of the conventional kinesin light chains, KLC1, displayed
slower accumulation of Mn2+ along the optic nerve but no decrease in trans-synaptic tracing.
Therefore, Mn2+ is not transported by KHC-KLC1 motor alone, other motors must be involved.
Thus the volume and concentration of Mn2+ injected for tracing must be carefully monitored,
and electrical activity of neuronal pathways will affect the efficiency of tracing circuits across
synapses.
Dependency on electrical activity of trans-neuronal transmission of Mn2+ makes this tracer
particularly useful for the study of progression of neurodegenerative disease. New hypotheses
in Alzheimer's disease and other neurodegenerative diseases propose that synapse loss is one
of the earliest events that correlate with memory impairments. Mn2+ transport rates and trans-
neuronal track tracing may thus be useful both to delineate anatomical projections of neurons
as well as to study anatomical and functional activity within individual neurons and along
circuits crossing several synapses. Mn2+ tracing will reveal the evolution of dysfunction in
neuronal circuitry in mouse models of disease and thus may provide significant insights about
disease progression not easily obtainable by any other means.
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Figure 1. Mn2+ injection into the eye affects electrical activity in response to light
Shown are graphs of averaged VEP measurements before, 4 hr, and 24 hr after injection of
various volumes of Mn2+ or saline solutions into the right eye of sighted C57/b6 mice (A-D).
In Fig.1A, VEP was measured with both eyes open. In B-D, VEPs were measured from the
injected right eye (red), the un-injected left eye (yellow), both eyes open (dark blue) or both
eyes closed (light blue). Full recovery occurred at 24 hr at lower doses.
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Figure 2. Injection of 0.25 μl saline has no effect on visual evoked potentials. CBA mice with rd−/
− have no response to light by VEP
(A) Injection of 0.25 μl saline had no effect on VEP of C57 wildtype mice at 4 hr (color code
is the same as in Fig. 1). (B) Preinjecton VEP measurements of three different CBA mice with
both eyes open demonstrated that they were functionally blind (CBA: red, yellow, and dark
blue) with no light response as compared to a C57 mouse tested on the same day (C57: light
blue).
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Figure 3. Time-lapse MRI of optic nerve enhancement after Mn2+ injection into the right eye of
sighted and blind mice
Shown are representative images of four of the mice used in this study, two sighted C57 and
two blind CBA. In each pair, the top sequence is from a young (6-8wk old) mouse and the
lower from an older (7 mo old) mouse. Images were captured at every 6 min. Shown are images
selected from these time-lapse sequences, beginning with the first, captured at 30 min post-
injection, and then at 1 hr, 1.5 hr and 2.5 hr post injection. At 24 hr after injection a similar
slab image bracketing the optic tract was captured. Similar images were obtained for all 5 CBA
young, 5 CBA old and 7 C57 mice of any age.
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Figure 4. Long-term effects of Mn2+ injection by histology
Optic nerve from an uninjected C57 mouse at low magnification (A) and high magnification
(B), and optic nerves from injected eye of C57 (C and E) and of CBA blind mouse (D and F).
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Figure 5. Ultrastructure of axons in the optic nerve from Mn2+ injected eyes
Representative examples of axons imaged by TEM within the right optic nerve of sighted C57
mouse (A) and blind CBA mouse (B) each injected with Mn2+ in the right eye are shown. Note
the dark myelin sheath encircling the axons, the dots within the axons representing cytoskeletal
elements in cross section, and the presence of cytoplasmic organelles within the axons
(arrowheads).
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Figure 6. Time-lapse MRI of optic nerve enhancement after Mn2+ injection into the right eye of
KLC+/+ (wildtype littermate) and KLC −/− mice
A) Representative images from two time-lapse sequences, KLC+/+ (top) and KLC −/− mice,
captured at 30 min, 1, 1.5 and 2.5 hr after injection of 0.25 μl of 200 mM Mn2+ into the right
eye. Note that by 2.5 hr after injection in the littermate, Mn2+ signal is present along the optic
nerve possibly reaching the chiasm. In contrast in the KLC−/− mouse, Mn2+ enhancement is
only detected in a short segment at the beginning of the optic nerve. B) At 24 hr Mn2+ signal
has progressed along the optic track in both genotypes, demonstrating that the optic tract is
intact. C) ROI intensity measurement (position indicated by circles in left panel) demonstrate
that over the first 160 min after Mn2+ injection into the vitreous, intensity (the ratio of optic
track vs. cheek muscle) increased in the optic tract by 150% in the wildtype KCL++ while no
intensity increase was detected in the KLC−/− mouse. Error bars represent the sum of the
standard deviations of the average voxel intensities in optic tract vs cheek muscle ROIs. For
KLC+/+ these were 10% and 6 % respectively, and for KLC−/− 7% and 6%.
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Figure 7. VEP of KLC mice
Shown are examples of VEPs from two mice, one KLC +/+ littermate (A) and one KLC −/−
knockout (B) before (blue) and at 24 hr (magenta) after Mn2+ injection into the right eye. Note
the delayed response to light after Mn2+ injection in both types of mouse, and the significant
decrease in signal intensity in the knockout at 24 hr.
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Figure 8. Mn2+ enhancement is greater in the midbrain at 24 hr post eye injection in C57/b6, KLC
−/− knockouts, than in blind CBA mice
A) Coronal sections through the midbrain taken from 3D MR images captured at 24 hr post
Mn2+ injection into the right eye are shown for mouse genotypes as indicated. Sections through
the lateral geniculate (left panels) or the superior colliculus (right panels) demonstrate Mn2+
induced increased intensity in C57 and KLC1−/− but no obvious increase in the blind CBA
mouse. B) ROI analysis of intensity in the eye, optic track, and midbrain (lateral geniculate
nucleus (LGN); and superior colliculus (sup coll). Wildtype (KLC+/+) is shown in blue, KLC
−/− in red, and rd−/− (blind) mice in yellow. Intensity values represent the ratio of average
voxel intensity in optic tract vs. standard tube, Error bars represent the sum of the standard
deviations of voxel intensities of the ROIs and the standard tube.
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Table 1
Strategy to determine the presence of the rd−/− mutation
Retinal blindness in the CBA mouse is caused by a proviral insert into intron I of the Pdeb gene which interferes
with normal transcription (top, diagram, adapted from Gimenez and Montoliu, 2001). The primer set that crosses
this insertion site (RD6 and RD3) produces a 0.4 kb product in rd+/+ mice lacking the insert and a much larger
9.1 kb product (not detectible) in rd−/− containing the insert. The converse is true when primer RD4 within the
proviral insert is combined with downstream intron primer RD3. In this case, PCR from DNA from rd−/− mouse
produces a 0.55kb product but no product is produced from rd+/+. If both alleles had been present, then two
products, one for each primer set, would be obtained. All mice in this study displayed only one product and thus
were homozygous for either rd+/+ or rd−/−.
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